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Tocopherols (chromanols) and tocopheryl quinones occur natu-
rally in biological membranes. Related 6-hydroxy-chromanones were
observed as byproducts of industrial tocopherol processing. Because
of the extensive use of some tocopherols as food supplements, the aim
of the study was to assess their inhibiting properties at the mam-
malian cytochrome bc1 complex as toxicological and pharmacological
target. The effects of these compounds and low molecular analogues
at the isolated cytochrome bc1 complex from bovine heart were
studied by dual-wavelength photometry, stopped ﬂow photometry,
and low temperature EPR spectroscopy. Our data show that α- and γ-
tocopherols as well as α-tocopheryl quinone required millimolar
concentrations to achieve half inhibition (IC50) of the decylubiquinol:
cytochrome c oxidoreductase activity. In contrast, γ-tocopheryl
quinone and the less lipophilic 6-hydroxy-4,4,7,8-tetramethyl-chro-
man-2-one (TMC2O) exhibited IC50 values of 117±6 and 94±12 µM,
respectively. Stopped ﬂow measurements of the reduction of cyto-
chromes in the isolated cytochrome bc1 complex revealed that TMC2O
preferably inhibited the cytochrome c1 reduction. EPR spectra of the
ascorbate-reduced Rieske iron sulfur protein at 20 K documented a
shift of gz from 2.0288±0.0005 (control) to 2.02240±0.0003 (TMC2O)
indicating a speciﬁc binding of this compound. Besides toxicological
implications for the effect of γ-tocopheryl quinone on the cytochrome
bc1 activity in vivo, our data suggest that synthetic modiﬁcations of
TMC2O could lead to a new class of cytochrome bc1 inhibitors.
doi:10.1016/j.bbabio.2008.05.410
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On the basis of the three-dimensional structures of the bc1
complex in the presence of the inhibitor stigmatellin, it is assumed
that the substrate quinol binding involves the cyt b glutamate residue
E272. However, this residue is not totally conserved during evolution:
in some β and γ-proteobacteria, it is replaced by valine or proline and
another glutamate is conserved and corresponds to H253 in yeast.
Studies of bc1 complexes with E272/H253 mutations will be pre-
sented. Replacement of E272 with apolar residues did not abolish the
bc1 activity, although it slowed down the kinetics of electron transfer.
The Kmvalue for the binding of the substrate quinol was not modiﬁed,
and the EPR data showed that the quinol binding still occurred in the
mutants. Binding of stigmatellin was retained, however mutations
E272P,V induced resistance toward myxothiazol. The pH dependence
of the bc1 activity was not modiﬁed in the absence of the glutamate
E272. Our results suggest that residue E272 may not be involved in
direct substrate binding or in its direct deprotonation. Revertants
were selected with polar residues serine and threonine at position
272. The data lead us to suggest that E272 may be involved in a later
step on the proton exit pathway via the interaction with a water
molecule.
doi:10.1016/j.bbabio.2008.05.411
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Thebc1 complex is a central complex in themitochondrial respiratory
chain. It links the transfer of electrons from ubiquinol (QH2) to
cytochrome c and proton translocation across the inner mitochondrial
membrane. It is widely agreed that the “Q-cycle mechanism” proposed
by Mitchell correctly describes the bc1 complex functioning. It is based
on an unexpected separation of the two electrons coming from the QH2
molecule bound at the Q0 site of the bc1 complex. One electron is
transferred to the iron–sulfur centre (FeS) of the iron sulphur protein
(ISP) and the second to the lower potential heme bL. The electron on
heme bL moves within the cytochrome b to reduce the higher potential
hemebH,which in turn reduces anubiquinone (Q)or a semiquinone (SQ)
at a second ubiquinone binding site Qi. Using a stochastic approach
based on the known spatial structure of bc1 complexes and the kinetic
parameters described by Moser and Dutton, we have demonstrated the
natural emergence of the Q-cycle mechanism and the quasi absence of
short-circuits in the functional dimer of bc1 complex without the
necessity to invoke any additional mechanism. In this poster we studied
the various parameters which inﬂuence the reaction between redox
centers. The natural distances measured on the crystallographic
structures appeared to minimize the short-circuits thus favouring an
energetic “Q-cycle” mechanism.
doi:10.1016/j.bbabio.2008.05.412
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Inhibitors of the mitochondrial respiratory chain enzyme cyto-
chrome bc1 – especially inhibitors targeting the Qo site of the enzyme –
have been developed as anti-microbial agents. They are used in
agriculture to control plant pathogenic fungi and in medicine against
human pathogens, such as the malaria parasite. Unfortunately, the
problem of acquired resistance has rapidly emerged. Resistance is
often linked to mutation within the mitochondrially-encoded cyto-
chrome b that forms the Qo site. To obtain information on the mole-
cular basis of the resistance and of the differential evolution of the
mutations, we used yeast (Saccharomyces cerevisiae) as a model
organism.Wemodiﬁed theQo site of yeast bc1 complex and introduced
variations and resistance mutations found in pathogens. The respira-
tory activity, the sensitivity to inhibitors and the ﬁtness of the yeast
mutants were then analyzed. In particular, we studied the resistance
mutations F129L, G137R and G143A found inmany pathogenic fungi of
important crops.We addressed the question of the impact of structural
variations in theQo site and of variations in the intron/exon structure of
the cytochrome b gene on the evolution of G143A. We also remodeled
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the yeast Qo pocket to mimic the Plasmodium falciparum and the
human enzymes.
doi:10.1016/j.bbabio.2008.05.413
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The cytochrome bc1 complex from Paracoccus denitriﬁcans is a
three-subunit transmembrane complex involved in the bacterial
aerobic respiratory chain. Its cytochrome c1 is made up of three
domains: a C-terminal transmembrane domain, a core domain which
covalently binds the redox cofactor, and an N-terminal acidic domain,
a unique feature in P. denitriﬁcans; it has a particular amino acidic
composition, which gives the subunit an overall negative charge
mostly due to the abundance of Glu residues. This feature has been
exploited for the puriﬁcation of the complex so far on ion exchange
chromatography. To analyze the role of this extra sequence, we cloned,
expressed, and puriﬁed a 10×His tagged mutant complex missing the
acidic domain. This complex has been characterized via SDS- and BN-
PAGE, Western Blots, kinetic tests, and LILBID MS. We obtained a fully
assembled complex, forming dimers (unlike the wild type which
forms tetramers), showing a standard activity of about 60% the wild
type. Fast kinetic experiments and further BN-PAGE analysis are
conducted presently to analyze the electron transfer between c1 and
c552, and the potential role of this deletion complex in the Paracoccus
respirasome.
doi:10.1016/j.bbabio.2008.05.414
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One of the differences between cytochrome bc1 and b6f complexes
is the presence of heme ci in the Qi binding site of the latter enzyme.
The X-ray crystallographic structure of the b6f complex showed that
heme ci is devoid of an axial protein ligand, leaving a vacant
coordination site that might be involved in Qi site turnover. In order
to understand the function of this peculiar cofactor we investigated its
presence and EPR characteristics in heliobacteria and in mutants of
the b6f complex from Chlamydomanas reinhardtii. EPR spectra and
biochemical analyses conﬁrmed the presence of heme ci in the Rieske/
cytochrome b complex from Heliobacteria. The spectra showed that a
strong axial (5th) ligand to the heme iron is present and structural
modelling places a Glu in a position suitable for heme ci ligation. We
compare the signature of heme ci in heliobacteria to a mutant of the
b6f complex were a Phe in the vicinity of heme ci iron was replaced by
a Tyr and to the wild-type b6f complex in the presence of NQNO. This
inhibitor has been shown to be a ligand to heme ci.
doi:10.1016/j.bbabio.2008.05.415
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The mitochondrial proteome is a precise description of the
chemical composition and functions of mitochondrial proteins. The
hydrophobicity of membrane proteins causes problems with their
analysis and under-representation in proteomes. Improvements in
membrane protein analyses have expanded our knowledge of the
mitochondrial proteome. Organic solvent combinations have been
employed for selective extraction of membrane proteins and also for
puriﬁcation with HILIC and reverse-phase chromatography on
macroporous supports. Importantly, these methods are compatible
with electrospray mass spectrometry and mitochondrial membrane
proteins have been characterised by molecular mass measurements
and identiﬁed directly by tandem mass spectrometry of intact
proteins. Molecular masses, for all thirteen hydrophobic products of
the bovine mitochondrial genome, demonstrate the absence of any
modiﬁcations other than N-formyl. These measurements have
resolved uncertainties concerning the interpretation of the mitochon-
drial genome. Also, the chemical composition of bovine mitochondrial
complex I has been ﬁnalised by the deﬁnition of the natural, stable
post-translational modiﬁcations on ND proteins. Sequence data from
tandem MS experiments on protein ions, have identiﬁed many
components of solvent extracts including some hydrophobic proteins
undetected by proteomic analyses of peptides. Two small hydrophobic
proteins of unknown function, DAPIT and a 6.8 kDa proteolipid
associate with ATP synthase complex in the presence of phospholi-
pids. The functions of others are under investigation.
doi:10.1016/j.bbabio.2008.05.416
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Protein phosphorylation is most probably the most abundant
reversible post translational modiﬁcation (PTM) in the human
proteome, regulated by 516 protein kinases and approx 100 protein
phosphatases. Although it is an abundant PTM, it is not the easiest to
study by conventional peptide mass spectrometry methods, as the
combination of low stoichiometry and poor ionisation leads to a low
representation of phosphopeptides in LC–MS based database
searches. Utilising the selective scanning features of a 4000 Q-Trap
mass spectrometer, such as precursor ion scanning and multiple
reaction monitoring (MRM), protein phosphorylation site identiﬁca-
tion by LC–MS has become more routine in our laboratory. The rapid
duty cycle of both precursor ion scanning and MRM permits
phosphopeptide detection and sequencing by ms/ms in an LC–MS
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